hnRNPU/TrkB Defines a Chromatin Accessibility Checkpoint for Liver Injury and Nonalcoholic Steatohepatitis Pathogenesis
Jing Xiong, Tongyu Liu, Lin Mi, Henry Kuang, Xuelian Xiong, Zhimin Chen, Siming Li, Jiandie D. Lin – 30 August 2019
Management of Patients With Erythropoietic Protoporphyria–Related Progressive Liver Disease
Zaid S. Ardalan, Sujievvan Chandran, Abhinav Vasudevan, Peter W. Angus, Andrew Grigg, Simon He, Graeme A. Macdonald, Simone I. Strasser, Courtney J. Tate, Glen A. Kennedy, Adam G. Testro, Paul J. Gow – 30 August 2019 – Erythropoietic protoporphyria (EPP) is an inherited metabolic disorder of heme synthesis resulting from overproduction of protoporphyrin IX (PPIX), which can lead to progressive liver disease characterized by recurrent EPP crises and end‐stage liver disease.
Master of Disguise: Hepatitis Delta Virus Packaging and Spread Facilitated by Diverse Viral Envelope Proteins
Stephanie Maya, Alexander Ploss – 29 August 2019
Mixed Fibrinolytic Phenotypes in Decompensated Cirrhosis and Acute‐on‐Chronic Liver Failure with Hypofibrinolysis in Those With Complications and Poor Survival
Annabel Blasi, Vishal C. Patel, Jelle Adelmeijer, Sarah Azarian, Maria Hernandez Tejero, Andrea Calvo, Javier Fernández, William Bernal, Ton Lisman – 29 August 2019
Elevated Fatty Liver Index as a Risk Factor for All‐Cause Mortality in Human Immunodeficiency Virus–Hepatitis C Virus–Coinfected Patients (ANRS CO13 HEPAVIH Cohort Study)
Tangui Barré, Camelia Protopopescu, Firouzé Bani‐Sadr, Lionel Piroth, Teresa Rojas Rojas, Dominique Salmon‐Ceron, Linda Wittkop, Laure Esterle, Philippe Sogni, Karine Lacombe, Julie Chas, Olivia Zaegel, Marie‐Laure Chaix, Patrick Miailhes, Lawrence Serfaty, Fabienne Marcellin, Maria Patrizia Carrieri, ANRS CO13 HEPAVIH Study Group – 29 August 2019
A Bile Duct‐on‐a‐Chip With Organ‐Level Functions
Yu Du, Gauri Khandekar, Jessica Llewellyn, William Polacheck, Christopher S. Chen, Rebecca G. Wells – 29 August 2019
A Prospective Trial of Withdrawal and Reinstitution of Ursodeoxycholic Acid in Pediatric Primary Sclerosing Cholangitis
Dennis D. Black, Cara Mack, Nanda Kerkar, Tamir Miloh, Shikha S. Sundaram, Ravinder Anand, Ashutosh Gupta, Estella Alonso, Ronen Arnon, Pinar Bulut, Saul Karpen, Chuan‐Hao Lin, Philip Rosenthal, Matthew Ryan, Robert H. Squires, Pamela Valentino, Sarah H. Elsea, Benjamin L. Shneider – 29 August 2019 – Ursodeoxycholic acid (UDCA) is commonly used to treat several liver disorders in adults and children, including primary sclerosing cholangitis (PSC) for which it is not U.S. Food and Drug Administration approved.
Appraisal of Cardiac Ejection Fraction With Liver Disease Severity: Implication in Post–Liver Transplantation Mortality
Hye‐Mee Kwon, Young‐Jin Moon, Kyeo‐Woon Jung, Yong‐Seok Park, Kyoung‐Sun Kim, In‐Gu Jun, Jun‐Gol Song, Gyu‐Sam Hwang – 28 August 2019
Timing of Choledochal Cyst Perforation
Mei Diao, Long Li, Wei Cheng – 28 August 2019
Postoperative Atrial Fibrillation and Flutter in Liver Transplantation: An Important Predictor of Early and Late Morbidity and Mortality
Rayan Jo Rachwan, Issa Kutkut, Taylor J. Hathaway, Lava R. Timsina, Chandrashekhar A. Kubal, Marco A. Lacerda, Marwan S. Ghabril, Patrick D. Bourdillon, Richard S. Mangus – 27 August 2019 – Postoperative atrial fibrillation/flutter (POAF) is the most common perioperative arrhythmia and may be particularly problematic after liver transplantation (LT). This study is a single‐center retrospective analysis of POAF to determine its incidence following LT, to identify risk factors, to assess its impact on clinical outcomes, and to summarize management strategies.